Fang Announced As NAI Senior Member
The National Academy of Inventors (NAI) proudly announced its 2024 class of Senior Members, honoring 124 distinguished academic inventors from NAI’s Member Institutions. Among them is UF innovator Ruogu Fang, Ph.D., recognized for being a rising leader in her field with success in patents, licensing, and commercialization, and for producing “technologies that have brought, or aspire to bring, real impact on the welfare of society.”
Global Food and Beverage Industry Representatives to Come to Orlando to Learn Latest Flavor Research
Flavor comes from a combination of nature and science. Food and beverage industry representatives from across the world will gather in Orlando in March to learn the research behind unique tastes and aromas.
Peak Strawberry Season Means More Florida-Grown, Flavorful Fruit at the Market
It's the height of the Florida strawberry harvesting season – a time when the state’s growers are doing all they can to make sure consumers can choose from among the best of their favorite fruit at the market.
Genetic Score Advances Personalized Treatment Strategies With Promising AML Drug
In the latest development in precision medicine approaches to treating pediatric leukemia, UF Health researchers have developed a genetic score to predict patient outcomes with a promising targeted drug treatment.
Axogen Announces Plan for CEO Leadership Transition
UF startup and UF Innovate | Sid Martin Biotech alum Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that President and Chief Executive Officer (CEO) Karen Zaderej plans to retire from the company by January 2025.
Study: UF Is World’s Top-Ranked Institution for Published Gene Therapy Research
The University of Florida is the world’s top contributor to scientific knowledge and literature about a widely used gene therapy technique, according to newly published research.
University of Florida Announces the 2023 National Academy of Inventors Fellows
The National Academy of Inventors has named two UF researchers to their 2023 class of distinguished academic inventors.
Atsena Therapeutics Announces Positive 12-Month Safety and Efficacy Data From Ongoing Phase I/II Clinical Trial To Treat Leber Congenital Amaurosis
Atsena Therapeutics announced positive results in their 12-month safety and efficacy data from the ongoing Phase I/II trial of ATSN-101, the company’s investigational gene therapy for the treatment of GUCY2D-associated Leber congenital amaurosis (LCA1). At 12 months post-treatment, ATSN-101 has conferred clinically meaningful improvements in vision at the highest dose with no serious treatment-emergent adverse events.
Tech Tuesday – Adam Veige
In this week's Tech Tuesday for WCJB TV20, UF Innovate's Melanie Morón interviews Adam Veige, professor in the UF Department of Chemistry and winner of an Invention of the Year award at StandingInnOvation 2023. He explains his invention, a cyclic version of polypropylene, which he aims to commercialize.
Combination of Two Common Compounds Improves COVID Survival in Mice, UF Researchers Find
Researchers at the University of Florida have discovered the combination of Lactoferrin, a protein found in cow and human milk, and diphenhydramine, an antihistamine used for allergy symptoms, increased resilience of mice towards the virus that causes COVID-19.
